ISAPP 2021 ANNUAL MEETING, JUNE 1 & 2
Plenary Session: Probiotics and prebiotics for the brain
Targeting the microbiota-gut-brain axis: Towards evidence based approaches for metabolic and mental health
ISAPP 2021 Annual Meeting: Harriët Schellekens, University College Cork, Ireland
Prebiotics and degenerative neurological disease
ISAPP 2021 Annual Meeting: Ali Keshavarzian, Rush University Medical Center, Chicago, USA
Plenary Session: Probiotics, COVID and vaccines
Probiotic COVID trials
ISAPP 2021 Annual Meeting: Paul Wischmeyer, Duke University, USA
Use of genetically engineered probiotic vaccines to prevent COVID
ISAPP 2021 Annual Meeting: Gregg Dean, Colorado State University, USA
Topical lactobacilli against respiratory viruses and their clinical application in COVID-19
ISAPP 2021 Annual Meeting: Irina Spacova & Ilke De Boek, University of Antwerp, Belgium
SFA Selected Talk
Blautia spp. Attenuates Gastrointestinal Toxicity Induced by 5-Fluorouracil Treatment
ISAPP 2021 Annual Meeting: Rita Ferreira, University of Groningen, The Netherlands
Panel with Longtime ISAPP Scientists
Ask us anything, we dare you
ISAPP 2021 Annual Meeting: Glenn Gibson, Bob Hutkins, Gregor Reid, Irene Lenoir-Wijnkoop, Mary Ellen Sanders
ISAPP MINI-SYMPOSIUM, JULY 1
The human mycobiome: An ISAPP mini-symposium
The human mycobiome: An ISAPP mini-symposium
This ISAPP mini-symposium features six short lectures that explore different aspects of the human mycobiome, including research, clinical and industry perspectives. The mini-symposium was hosted by ISAPP board members Mary Ellen Sanders & Eamonn Quigley, with presentations by Pauline Scanlan, Heather Hallen-Adams, Iliyan Iliev, Joseph Petrosino, Eamonn Quigley and Frank Schuren.
